Skip to main content

Animations

MJFF Publications

5361 - 5370 of 9118 Results
Title
Year
  • Year
  • 2021
  • 2022
  • 2018
  • 2010
  • 2026
  • 2019
  • 2015
  • 2016
  • 2025
  • 2026
  • Summary Details
    OPEN
    Title: Double blind randomized controlled trial of deep brain stimulation for obsessive-compulsive disorder: Clinical trial design
    Journal Name: Contemporary Clinical Trials Communications
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.conctc.2021.100785
    Citation Count: 17
  • Summary Details
    OPEN
    Title: Level I PD‐MCI Using Global Cognitive Tests and the Risk for Parkinson's Disease Dementia
    Journal Name: Movement Disorders Clinical Practice
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/mdc3.13451
    Citation Count: 29
  • Summary Details
    OPEN
    Title: USP 14 inhibition corrects an in vivo model of impaired mitophagy
    Journal Name: EMBO Molecular Medicine
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.15252/emmm.201809014
    Citation Count: 118
  • Summary Details
    OPEN
    Title: Effects of intrastriatal GDNF on the response of dopamine neurons to 6-hydroxydopamine: Time course of protection and neurorestoration
    Journal Name: Brain Research
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.brainres.2010.11.006
    Citation Count: 41
  • Summary Details
    OPEN
    Title: The emerging role and therapeutic targeting of autophagy-lysosome pathway in the pathogenesis of Parkinson’s disease
    Journal Name: Translational Neurodegeneration
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s40035-026-00555-3
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Safety and efficacy of epigallocatechin gallate in multiple system atrophy (PROMESA): a randomised, double-blind, placebo-controlled trial
    Journal Name: The Lancet Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/s1474-4422(19)30141-3
    Citation Count: 126
  • Summary Details
    OPEN
    Title: Low‐variance RNAs identify Parkinson's disease molecular signature in blood
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.26205
    Citation Count: 20
  • Summary Details
    OPEN
    Title: Problematic Mobile Gaming in Parkinson's Disease: An Impulse Control Disorder for the Smartphone
    Journal Name: Movement Disorders Clinical Practice
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mdc3.12378
    Citation Count: 5
  • Summary Details
    OPEN
    Title: A dose-finding study shows terazosin enhanced energy metabolism in neurologically healthy adults
    Journal Name: Journal of Parkinson’s Disease
    Publisher: SAGE Publications
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1177/1877718x251356503
    Citation Count: 2
  • Summary Details
    OPEN
    Title: The Age at Onset of LRRK2 p. Gly2019Ser Parkinson's Disease Across Ancestries and Countries of Origin
    Journal Name: Annals of Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/ana.78181
    Citation Count: 0
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.